These allegations have led to questions about the drugs safety and efficacy
The increase in heart rate, along with any flushing or warmth, is transient
7583% achieved 15% 26% of participants on 12 mg achieved 30% weight reduction Cardiometabolic Parameters Improvements in blood pressure, HbA1c, fasting glucose, insulin, LDL-cholesterol 72% of patients with prediabetes achieved normoglycemia Safety Most common adverse events: gastrointestinal (nausea, diarrhea, constipation) , dose-dependent, predominantly mild to moderate Heart rate: slight increase up to week 24, then decrease No severe hypoglycemia, medullary carcinoma, or C-cell hyperplasia Conclusions Retatrutide induced significant, dose-dependent weight reduction of up to 24.2% over 48 weeks
Our team of lawyers specializing in Ozempic cases will guide you through the legal process, taking care of essential steps such as gathering evidence and assessing damages
Changing Market Dynamics Speaking of convenience, current GLP-1 medications for weight loss take the form of injectables, but oral versions are on the horizon, and the price will likely be lower